Ordinance
on Clinical Trials
with the exception of
Clinical Trials of Medical Devices1
(Clinical Trials Ordinance, ClinO)

of 20 September 2013 (Status as of 26 May 2022)

1 Amended by Annex 2 No 2 of the O of 1 July 2020 on Clinical Trials with Medical Devices, in force since 26 May 2021 (AS 2020 3033).


Open article in different language:  DE  |  FR  |  IT
Art. 62 Applicable provisions

The pro­vi­sions which ap­ply mu­tatis mutandis are:

a.
for the au­thor­isa­tion pro­ced­ure for clin­ic­al tri­als, Art­icles 24–29;
b.
for the no­ti­fic­a­tion of safety and pro­tect­ive meas­ures, Art­icle 37 para­graph 1;
c.
for no­ti­fic­a­tion and re­port­ing upon com­ple­tion, dis­con­tinu­ation or in­ter­rup­tion of a clin­ic­al tri­al, Art­icle 38 para­graphs 1–4;
d.
for re­port­ing on the safety of par­ti­cipants, Art­icle 43 para­graphs 1 and 2;
e.
for data re­ten­tion re­quire­ments, Art­icle 45 para­graph 2.

Diese Seite ist durch reCAPTCHA geschützt und die Google Datenschutzrichtlinie und Nutzungsbedingungen gelten.

Feedback
Laden